Clinigen Group (CLIN)

 

Latest News

Clinigen and Diurnal partner for MA programme

Clinigen Group's Idis managed access division and Diurnal Group have partnered to launch a managed access programme...

Clinigen and Diurnal partner for MA programme

RNS Number: 6111Z Clinigen Group plc 16 March 2017 16 March 2017 RNS Reach Clinigen and Diurnal partner for European Managed Access programme for Infacort and Chronocort Clinigen Group plc's (AIM: CLIN, 'Clinigen' or the 'Group') Idis Managed Access (MA) division and Diurnal Group plc (AIM: DNL, 'Diurnal') , have partnered to launch a Managed Acc...

Launch of a European Patient Access programme

RNS Number: 6197Z Diurnal Group PLC 16 March 2017 16 March 2017 Diurnal Group plc ("Diurnal" or the "Company") Diurnal appoints Clinigen to launch a European Patient Access programme for Infacort and Chronocort Infrastructure and supply chain now in place to provide Infacort and Chronocort as unlicensed medicines to patients on a Named Patient b...

Clinigen hikes divi as gross profits rise

Global pharmaceuticals and services company Clinigen's adjusted gross profits rose to 59.1m in the six months to the end of...

All News

DateHeadlineSource
16-03-17Clinigen and Diurnal partner for MA programmeStockMarketWire
16-03-17Clinigen and Diurnal partner for MA programmeRNS
16-03-17Launch of a European Patient Access programmeRNS
15-03-17Clinigen hikes divi as gross profits rise StockMarketWire
15-03-17Half-year ReportRNS
10-03-17First-in-class Fycompa? approved in South AfricaRNS
09-03-17Holding(s) in CompanyRNS
28-02-17Halaven? (eribulin) launches in South AfricaRNS
24-02-17Broker Forecast - Peel Hunt issues a broker note on Clinigen GroupStockMarketWire
22-02-17Notification of half year results dateRNS
25-01-17Broker Forecast - Stifel issues a broker note on Clinigen GroupStockMarketWire
25-01-17Broker Forecast - N+1 Singer issues a broker note on Clinigen GroupStockMarketWire
25-01-17Clinigen gross profit up 34%StockMarketWire
25-01-17HY trading updateRNS
17-01-17Clinigen initiates programme for TESARO inhibitorStockMarketWire
17-01-17Clinigen initiates program for TESARO's niraparibRNS
13-01-17Change of Joint BrokerRNS
09-01-17Clinigen and Cumberland enter agreement for TotectStockMarketWire
09-01-17Clinigen and Cumberland enter agreement for TotectRNS
15-12-16Clinigen signs agreement with BioQ PharmaRNS
01-12-16Clinigen collaborates with Eisai in South AfricaStockMarketWire
01-12-16Clinigen collaborates with Eisai in South AfricaRNS
14-11-16Director Deals - Clinigen Group (CLIN)StockMarketWire
14-11-16Director/PDMR ShareholdingRNS
11-11-16Clinigen resolutions passed at AGMStockMarketWire
11-11-16Result of AGMRNS
11-11-16Clinigen says FY trading in-lineStockMarketWire
11-11-16AGM StatementRNS
10-11-16Holding(s) in CompanyRNS
04-11-16Capital Markets DayRNS
25-10-16Clinigen and BTG extend global partnershipStockMarketWire
25-10-16BTG partnership extended with new GA agreementRNS
24-10-16Clinigen grants options StockMarketWire
24-10-16Grant of share optionsRNS
21-10-16Clinigen options exercised StockMarketWire
21-10-16Issue of EquityRNS
20-10-16Holding(s) in CompanyRNS
19-10-16Director Deals - Clinigen Group (CLIN)StockMarketWire
19-10-16Director Deals - Clinigen Group (CLIN)StockMarketWire
19-10-16Director Deals - Clinigen Group (CLIN)StockMarketWire

RSS feeds

  • Editorial news feed for LSE:CLIN Editorial
  • Regulatory news feed for LSE:CLIN Regulatory